Articles dans des revues avec comité de lecture (182)
  1. 70. Asselah, T., Lenz, O., Van Dooren, G., Nalpas, C., Lonjon-Domanec, I., Schlag, M., Buti, M., Moreno, C., Sarrazin, C., Gschwantler, M., Foster, G. G., Craxí, A., Buggisch, P., Sanai, F., & Bicer, C. (2017). Efficacy of a 12-week simeprevir plus peginterferon/ribavirin (PR) regimen in treatment-naïve patients with hepatitis C virus (HCV) genotype 4 (GT4) infection and mild-to-moderate fibrosis displaying early on-treatment virologic response. PloS one, 12(1), e0168713. doi:10.1371/journal.pone.0168713
  2. 71. Karakike, E., Moreno, C., & Gustot, T. (2017). Infections in severe alcoholic hepatitis. Annals of Gastroenterology, 30(2), 152-160. doi:10.20524/aog.2016.0101
  3. 72. Stickel, F., Moreno, C., Hampe, J., & Morgan, M. Y. (2017). The genetics of alcohol dependence and alcohol-related liver disease. Journal of hepatology, 66(1), 195-211. doi:10.1016/j.jhep.2016.08.011
  4. 73. Bruyneel, M., Serste, T., Libert, W., Van Den Broecke, S., Ameye, L., Dachy, B., Mulkay, J.-P., Moreno, C., & Gustot, T. (2017). Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin. European journal of gastroenterology & hepatology, 29(3), 302-308. doi:10.1097/MEG.0000000000000786
  5. 74. Foster, G. R., Heo, J., Kumada, H., Lu, S. N., Marcellin, P., Moreno, C., Roberts, S. K. E. S., Strasser, S., Thompson, A. J. V. A., Toyota, J., Paik, S. W., Chayama, K., Vierling, J. J., Zignego, A. L., Cohen, D., McPhee, F., Wind-Rotolo, M., Srinivasan, S., Hruska, M., Myler, H., Portsmouth, S. S., Chuang, W. L., Fainboim, H., Färkkilä, M., Gadano, A., Gaeta, G. B. A. G., Hezode, C., & Inada, Y. (2016). A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3. SpringerPlus, 5(1), 1365. doi:10.1186/s40064-016-2920-z
  6. 75. Coilly, A., Leroy, V., Canva, V., Lebray, P., Moreno, C., Dumortier, J., Silvain, C., Besch, C., Perre, P., Botta-Fridlund, D., Anty, R., Fougerou-Leurent, C., Francoz, C., Abergel, A., Debette-Gratien, M., Conti, F., Habersetzer, F., Rohel, A., Rossignol, E., Danjou, H., Roque-Afonso, A. M., Samuel, D., De Ledinghen, V., Duclos-Vallée, J.-C., Pageaux, G.-P., Houssel-Debry, P., Duvoux, C., Di Martino, V., Radenne, S., Kamar, N., & D'Alteroche, L. (2016). Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study. Journal of hepatology, 65(4), 711-718. doi:10.1016/j.jhep.2016.05.039
  7. 76. Dumortier, J., Canva, V., Di Martino, V., Conti, F., Kamar, N., Moreno, C., Lebray, P., Tran, A., Besch, C., Diallo, M. A., Rohel, A., Leroy, V., Rossignol, E., Abergel, A., Botta-Fridlund, D., Coilly, A., Samuel, D., Duclos-Vallée, J.-C., Pageaux, G.-P., Duvoux, C., De Ledinghen, V., Francoz, C., Houssel-Debry, P., Radenne, S., D'Alteroche, L., & Fougerou-Leurent, C. (2016). Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation. Liver transplantation, 22(10), 1367-1378. doi:10.1002/lt.24505
  8. 77. Moreno, C., & Domngang, D. (2016). Prise en charge de l'hépatite C chronique en 2016. Revue médicale de Bruxelles, 37(4), 283-288.
  9. 78. Vandenbulcke, H., Delwaide, J., Orlent, H., Lasser, L., Trepo, E., Van Vlierberghe, H., Michielsen, P., Van Gossum, M., De Vos, M.-J., Marot, A., Doerig, C., Moreno, C., Henrion, J., Deltenre, P., Colle, I., Knebel, J. F., Francque, S., Serste, T., George, C., De Galocsy, C., & Laleman, W. (2016). Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study. Journal of hepatology, 65(3), 543-551. doi:10.1016/j.jhep.2016.04.031
  10. 79. Degré, D., Gustot, T., Gerkens, A., Boon, N., Schreiber, J., Lepida, A., Serste, T., Deltenre, P., Devière, J., Trepo, E., & Moreno, C. (2016). Insulin resistance is associated with esophageal varices in alcoholic liver disease patients. European journal of gastroenterology & hepatology, 28(7), 792-796. doi:10.1097/MEG.0000000000000627
  11. 80. Asselah, T., Scott, J. T., Van Dooren, G., Lonjon-Domanec, I., Schlag, M., Buti, M., Moreno, C., Sarrazin, C., Gschwantler, M., Foster, G. R., Craxí, A., Buggisch, P., Ryan, R., & Lenz, O. (2016). An open-label trial of 12-week simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with Hepatitis C Virus (HCV) Genotype 1 (GT1). PloS one, 11(7), e0158526. doi:10.1371/journal.pone.0158526
  12. 81. Bourgeois, S., Van Damme, P., Van Vlierberghe, H., Vandijck, D., Moreno, C., Blach, S., Brixko, C., Laleman, W., Matheï, C., Mulkay, J.-P., Razavi, H., Robaeys, G., & Starkel, P. (2016). Achieving WHO recommendations for hepatitis C virus elimination in Belgium. Acta gastro-enterologica Belgica (Ed. multilingue), 79(2), 222-226.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>